These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2741190)

  • 1. High blood concentrations of imipramine or clomipramine and therapeutic failure: a case report study using drug monitoring data.
    Balant-Gorgia AE; Balant LP; Garrone G
    Ther Drug Monit; 1989; 11(4):415-20. PubMed ID: 2741190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Debrisoquine hydroxylation phenotypes of patients with high versus low to normal serum antidepressant concentrations.
    Tacke U; Leinonen E; Lillsunde P; Seppälä T; Arvela P; Pelkonen O; Ylitalo P
    J Clin Psychopharmacol; 1992 Aug; 12(4):262-7. PubMed ID: 1527229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine in depressed patients: a comparison with imipramine.
    Bremner JD
    J Clin Psychiatry; 1984 Oct; 45(10):414-9. PubMed ID: 6384203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of Hydiphen in the treatment of endogenous depression].
    Nowakowska C; Chłopocka-Woźniak M; Strzyzewski W
    Psychiatr Pol; 1989; 23(1):10-7. PubMed ID: 2682710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind comparison of amoxapine and imipramine in the treatment of depressed patients.
    Gelenberg AJ; Wojcik JD; Lydiard RB; McCormick MG; Falk WE; Hicks RH; Curren FC; Cohen BM
    J Clin Psychiatry; 1984 Feb; 45(2):54-56, 57-9. PubMed ID: 6363397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of oxidative polymorphism and levomepromazine treatment on the steady-state blood concentrations of clomipramine and its major metabolites.
    Balant-Gorgia AE; Balant LP; Genet C; Dayer P; Aeschlimann JM; Garrone G
    Eur J Clin Pharmacol; 1986; 31(4):449-55. PubMed ID: 2880723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma level monitoring of antidepressants: theoretical basis and clinical application.
    Gram LF; Kragh-Sørensen P; Kristensen CB; Møller M; Pedersen OL; Thayssen P
    Adv Biochem Psychopharmacol; 1984; 39():399-411. PubMed ID: 6380231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring in depression.
    Radziwoń-Zaleska M; Matsumoto H; Skalski M; Androsiuk W; Dziklińska A; Kunicki PK
    Pol J Pharmacol; 2000; 52(4):255-66. PubMed ID: 11345481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder.
    Bakish D; Lapierre YD; Weinstein R; Klein J; Wiens A; Jones B; Horn E; Browne M; Bourget D; Blanchard A
    J Clin Psychopharmacol; 1993 Dec; 13(6):409-14. PubMed ID: 8120154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
    Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
    J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic monitoring of treatment with antidepressants.
    Bourin MS; Kergueris MF; Lapierre YD
    Psychiatr J Univ Ott; 1989 Sep; 14(3):460-2. PubMed ID: 2678187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic drug monitoring in depression--new perspectives].
    Radziwoń-Zaleska M; Matsumoto H; Skalski M; Dziklińska A; Androsiuk W; Wakarow A; Wilkowska J; Matoszko D; Kuczyńska J; Goluch J
    Psychiatr Pol; 2002; 36(6 Suppl):71-80. PubMed ID: 12647424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma levels of clomipramine and declomipramine in patients with depression: a study of its correlation with therapeutic efficacy].
    Wargny E; Lamiable D; Havet JM; Denis J; Millart H; Choisy H; Pascalis G
    Ann Med Psychol (Paris); 1986 Apr; 144(4):396-406. PubMed ID: 3813333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--III. Standard-controlled clinical trial.
    Pecknold JC; Gratton L; Ban TA; Klingner A
    Psychopharmacol Bull; 1976 Jan; 12(1):26-7. PubMed ID: 1108079
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical experience with maprotilin and maprotilin/clomipramine infusions in resistant depression.
    Zapletálek M; Zbytovský J; Kudrnová K
    Act Nerv Super (Praha); 1982 May; 24(2):73-6. PubMed ID: 7102227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early response patterns associated with successful clomipramine treatment.
    Pollock BG; Perel JM; Kupfer DJ; Bowler KA; Miewald JM
    J Clin Psychopharmacol; 1993 Dec; 13(6):442-7. PubMed ID: 8120158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipramine blood levels and clinical outcome.
    Rigal JG; Albin HC; Duchier AR; D'Aulnay JM; Fenelon JH; Vincon GA; Demotes-Mainard FM
    J Clin Psychopharmacol; 1987 Aug; 7(4):222-9. PubMed ID: 3624505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
    Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacogenetics of antidepressant metabolism. Value of the debrisoquin test].
    Baumann P
    Encephale; 1986; 12(4):143-8. PubMed ID: 3792273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary MHPG is not a good predictor of antidepressive drug response.
    Puzyński S; Rode A; Bidziński A; Mrozek S; Załuska M
    Pol J Pharmacol Pharm; 1984; 36(4):329-35. PubMed ID: 6527968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.